Perturbation of mouse glioma MRS pattern by induced acute hyperglycemia

NMR in Biomedicine

Volumn 21, Issue 3, 2008, Pages 251-264

  Simoes R V ^a,b   Garcia Martin M L ^c   Cerdan S ^c   Arús, Carles ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

Brain; GL261 glioma cells; Hyperglycemia; Mouse; Tumor biomarker; Tumor metabolism; Tumor pattern

Indexed keywords

BIOMARKERS; BLOOD; BRAIN; GLUCOSE; METABOLISM; RATS;

GLIOMA CELLS; HYPERGLYCEMIA; TUMOR BIOMARKER; TUMOR METABOLISM; TUMOR PATTERN;

TUMORS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GLIOMA; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPERGLYCEMIA; IMAGE ANALYSIS; IMAGE DISPLAY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RELAXATION TIME; SPECTROSCOPY; TUMOR CLASSIFICATION;

ANIMALS; BLOOD GLUCOSE; BRAIN; FEMALE; GLIOMA; GLUCOSE; HUMANS; HYPERGLYCEMIA; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED C57BL; NEOPLASM STAGING;

ANIMALIA; MUS;

EID: 41949133892     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1188     Document Type: Article

References (53)

1. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001; 15: 1311-1333.
2. Zhu Y, Parada LF. The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002; 2: 616-626.
3. McKnight TR. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Semin Oncol. 2004; 31: 605-617.
4. 1H MR spectroscopy of brain tumours and masses. NMR in Biomedicine. 2003; 16: 123-131.
5. Tate AR, Underwood J, Acosta DM, Julià-Sapé M, Majós C, Moreno-Torres A, Howe FA, van der Graaf M, Lefournier V, Murphy MM, Loosemore A, Ladroue C, Wesseling P, Luc Boston J, Cabañas ME, Simonetti AW, Gajewicz W, Calvar J, Capdevila A, Wilkins PR, Bell BA, Rémy C, Heerschap A, Watson D, Griffiths JR, Arús C. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed. 2006; 19: 411-434.
6. Galanaud D, Nicoli F, Chinot O, Confort-Gouny S, Figarella-Branger D, Roche P, Fuentes S, Le Fur Y, Ranjeva JP, Cozzone PJ. Noninvasive diagnostic assessment of brain tumors using combined in vivo MR imaging and spectroscopy. Magn Reson Med. 2006; 55: 1236-1245.
7. Smirniotopoulos JG. The new WHO classification of brain tumors. Neuroimaging Clin North Am. 1999; 9: 595-613.
8. Mischel PS, Cloughesy TF, Nelson SF. DNA-microarray analysis of brain cancer: molecular classification for therapy. Nat Rev Neurosci. 2004; 5: 782-792.
9. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006; 9: 157-173.
10. Siesjö BK. Brain Energy Metabolism. Wiley: New York, 1978: 106-115.
11. Rhodes CG, Wise RJ, Gibbs JM, Frackowiak RS, Hatazawa J, Palmer AJ, Thomas DG, Jones T. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas. Ann Neurol. 1983; 14: 614-626.
12. 1H magnetic resonance imaging. Cancer Res. 2001; 61: 5595-5600.
13. Gyngell ML, Michaelis T, Hörstermann D, Bruhn H, Hänicke W, Merboldt KD, Frahm J. Cerebral glucose is detected by localized proton NMR spectroscopy in normal rat brain in vivo. Magn Reson Med. 1991; 19: 489-495.
14. 1H NMR difference spectra of the human brain. Magn Reson Med. 1992; 27: 183-188.
15. Bruhn H, Michaelis T, Merboldt KD, Hanicke W, Gyngell ML, Frahm J. Monitoring cerebral glucose in diabetics by proton MRS. Lancet. 1991; 337: 745-746.
16. 1H MRS. Magn Reson Med. 1993; 30: 18-27.
17. Terpstra M, Gruetter R, High WB, Mescher M, DelaBarre L, Merkle H, Garwood M. Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. Cancer Res. 1998; 58: 5083-5088.
18. Moreno-Torres A, Martínez-Pérez I, Baquero M, Campistol J, Capdevila A, Arús C, Pujol J. Taurine detection by proton magnetic resonance spectroscopy in medulloblastoma: contribution to noninvasive differential diagnosis with cerebellar astrocytoma. Neurosurgery. 2004; 55: 824-829.
19. von Kienlin M, Ziegler A, Le Fur Y, Rubin C, Décorps M, Rémy C. 2D-spatial/2D-spectral spectroscopic imaging of intracerebral gliomas in rat brain. Magn Reson Med. 2000; 43: 211-219.
20. Seligman AM, Shear MJ. Studies in carcinogenesis. VIII. Experimental production of Brain tumors in mice with methylcholanthrene. Am. J. Cancer 1939; 37: 364-395.
21. Cha S, Johnson G, Wadghiri YZ, Jin O, Babb J, Zagzag D, Turnbull DH. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med. 2003; 49: 848-855.
22. Martin A, Rojas S, Chamorro A, Falcon C, Bargallo N, Planas AM. Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? Role of corticosteroids, inflammation, and protein O-glycosylation. Stroke. 2006; 37: 1288-1295.
23. Hennig J, Nauerth A, Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn Reson Med. 1986; 3: 823-833.
24. Al-Attar SA, Pollex RL, Robinson JF, Miskie BA, Walcarius R, Rutt BK, Hegele RA. Semi-automated segmentation and quantification of adipose tissue in calf and thigh by MRI: a preliminary study in patients with monogenic metabolic syndrome. BMC Med Imaging. 2006; 6: 11-19.
25. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time dependent field gradient. J Chem Phys. 1965; 42: 288-292.
26. Garcia-Martin ML, Martinez GV, Raghunand N, Sherry AD, Zhang S, Gillies RJ. High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magn Reson Med. 2006; 55: 309-315.
27. Ernst T, Hennig J. Improved water suppression for localized in vivo 1H spectroscopy. J Magn Reson B. 1995; 106: 181-186.
28. 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med. 1999; 4: 649-656.
29. Bolan PJ, Meisamy S, Baker EH, Lin J, Emory T, Nelson M, Everson LI, Yee D, Garwood M. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med. 2003; 50: 1134-1143.
30. Navarro-Vazquez A, Cobas JC, Sardina FJ, Casanueva J, Diez E. A graphical tool for the prediction of vicinal proton-proton 3J(HH) coupling constants. J Chem Inf Comput Sci. 2004; 44: 1680-1685.
31. 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease. J Neurosci. 2005; 25: 1691-1700.
32. Terpstra M, High WB, Luo Y, de Graaf RA, Merkle H, Garwood M. Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma. NMR Biomed. 1996; 9: 185-194.
33. Ihaka R, Gentleman R. A language for data analysis and graphics. J Comput Graph Stat. 1996; 5: 299-314.
34. Valverde D, Candiota A, Molins M, Feliz M, Martino J, Godino O, Acebes J, Arús C. Temperature effect on the HRMAS spectra of human brain tumour biopsies and their pattern recognition analysis. Magn. Reson. Mater. Phy, MAGMA. 2006; 19: 165-166.
35. Tate AR, Griffiths JR, Martinez-Perez I, Moreno A, Barba I, Cabanas ME, Watson D, Alonso J, Bartumeus F, Isamat F, Ferrer I, Vila F, Ferrer E, Capdevila A, Arús C. Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed. 1998; 11: 177-191.
36. Zagzag D, Amirnovin R, Greco MA, Yee H, Holash J, Wiegand SJ, Zabski S, Yancopoulos GD, Grumet M. Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest. 2000; 80: 837-849.
37. Candiota AP, Majos C, Bassols A, Cabanas ME, Acebes JJ, Quintero MR, Arus C. Assignment of the 2.03 ppm resonance in in vivo 1H MRS of human brain tumour cystic fluid: contribution of macromolecules. Magn. Reson. Mater. Phy, MAGMA. 2004; 17: 36-46.
38. Quintero M, Cabañas ME, Arús C. A possible cellular explanation for the NMR-visible mobile lipid (ML) changes in cultured C6 glloma cells with growth. Biochim Biophys Acta. 2007; 177: 31-44.
39. Candiota A, Majós C, Julià-Sapé M, Cabañas M, Mercadal G, Acebes JJ, Moreno-Torres A, Griffiths JR, Arús C. Myo-Inositol and glycine content measurement for grading astrocytic tumours with in vivo MRS. Proceedings ESMRMB. Magn. Reson. Mater Phy, MAGMA. 2005; 7: 176-307(s193).
40. 1H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice. Eur J Neurosci. 2006; 23: 1077-1081.
41. Schwarcz A, Natt O, Watanable T, Boretius S, Frahm J, Michaelis T. Localized proton MRS of different mouse strains. Magn Reson Med. 2003; 49: 822-827.
42. 1H NMR spectroscopy of the mouse brain at 9.4 T. Magn Reson Med. 2004; 52: 478-484.
43. 1H NMR spectroscopy. Magn Reson Med. 1992; 27: 356-361.
44. Loginov VM, Vorob'ev IuV, Khalanskii AS, Kachkov IA, Promyslov MSh. [Concentration of lactate concentration in experimental glial tumors and brain tissue during brief artificial hyperglycemia]. Zh Vopr Neirokhir Im N N Burdenko. 1985; 2: 31-35.
45. 1H NMR spectra of the human brain at 4 tesla. Magn Reson Med. 1996; 36: 1-6.
46. 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. Cancer Res. 2001; 61: 6524-6531.
47. Hossmann KA, Mies G, Paschen W, Szabo L, Dolan E, Wechsler W. Regional metabolism of experimental brain tumors. Acta Neuropathol (Berl). 1986; 69: 139-147.
48. 1H nuclear magnetic resonance spectroscopy in vivo. J Cereb Blood Flow Metab. 2000; 20: 736-746.
49. Loginov VM, Promyslov MSh, Kachkov IA, Khalanskii AS. [Concentration of glucose in the tissues of glial tumors of the brain in rats with artificial hyperglycemia of short duration]. Zh Vopr Neirokhir Im N N Burdenko. 1984; 1: 24-27.
50. Kallinowski F, Schlenger KH, Runkel S, Kloes M, Stohrer M, Okunieff P, Vaupel P. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res. 1989; 49: 3759-3764.
51. + transport in the interstitial fluid. Novartis Found Symp. 2001; 240: 46-62.
52. de Graaf RA, Brown PB, McIntyre S, Nixon TW, Behar KL, Rothman DL. High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo. Magn Reson Med. 2006; 56: 386-394.
53. 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med. 2001; 46: 451-456.